Woodmont Investment Counsel’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Woodmont Investment Counsel’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,225	Closed	–	–	739
2016 Q3	$0	Buy	+1,225	New	+$283	﹤0.01%	755
2016 Q2	–	Sell	-1,225	Closed	–	–	523
2016 Q1	$0	Hold	1,225	–	–	﹤0.01%	563
2015 Q4	$2K	Hold	1,225	–	–	﹤0.01%	512
2015 Q3	$2K	Buy	+1,225	New	+$2.92K	﹤0.01%	513

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Woodmont Investment Counsel's TLOG Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 1,225 shares.

Woodmont Investment Counsel first reported a position in TLOG in Q3 2015 and held it in 4 quarters. The position peaked at $2K in Q4 2015. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Woodmont Investment Counsel reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Woodmont Investment Counsel sold 1,225 TetraLogic Pharmaceuticals Corporation shares in Q4 2016.
Woodmont Investment Counsel first reported a position in TetraLogic Pharmaceuticals Corporation in Q3 2015 and held it in 4 quarters.
Woodmont Investment Counsel's TetraLogic Pharmaceuticals Corporation position peaked at $2K in Q4 2015.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.